Winchester, MA, United States of America

Michael S O'Reilly

This inventor holds 26 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Children's Medical Center Corporation, Children's Hospital, Cincinnati Children's Hospital Medical Center. Active years: 1997-2011.

USPTO Granted Patents = 26 (Patent Applications = 4)

% Patents Active = 92.3

EPO Patents = 1

Average Co-Inventor Count = 2.4

ph-index = 13

Forward Citations = 711(Granted Patents)

Location History:

Houston, TX (US) (2009)
Winchester, MA (US) (1997 - 2010)
Missouri City, TX (US) (2009 - 2011)

Company Filing History:

24 out of 1,072

Children's Medical Center Corporation

Cincinnati Children's Hospital Medical Center

patents

Years Active: 1997-2011

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7867975 - Therapeutic antiangiogenic endostatin compositions (2011-01-11),

2. 7655458 - Nucleic acid molecules encoding endostatin protein and peptide fragments thereof (2010-02-02),

3. 7495089 - Therapeutic antiangiogenic endostatin compositions (2009-02-24),

4. 7485439 - Nucleic acids encoding plasminogen fragments and methods of use (2009-02-03),

5. 7365159 - Angiostatin protein (2008-04-29),

6. 7179608 - Therapeutic antiangiogenic compositions and methods (2007-02-20),

7. 7101979 - Antibodies to antiangiogenic compositions and methods (2006-09-05),

8. 6949511 - Methods of inhibiting angiogenesis via increasing in vivo concentrations of kringle region fragments of plasminogen (2005-09-27),

9. 6764995 - Endostatin protein and fragments thereof (2004-07-20),

10. 6630448 - Methods of inhibiting angiogenesis with endostatin protein (2003-10-07),

11. 6607724 - Compositions and methods for inhibiting angiogenesis (2003-08-19),

12. 6544758 - Methods for expressing endostatin protein (2003-04-08),

13. 6521439 - Nucleic acids encoding plasminogen fragments (2003-02-18),

14. 6346510 - Therapeutic antiangiogenic endostatin compositions (2002-02-12),

15. 6174861 - Methods of inhibiting angiogenesis via increasing in vivo concentrations of endostatin protein (2001-01-16),

Title: The Innovative Mind of Michael S. O'Reilly

Introduction:

Michael S. O'Reilly, a distinguished inventor hailing from Winchester, MA, has made significant contributions to the field of technology and innovation.

Latest Patents:

Michael S. O'Reilly holds several patents in the areas of telecommunications, software development, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights:

With a background in engineering and a passion for problem-solving, Michael has enjoyed a successful career marked by groundbreaking inventions that have improved the lives of many.

Collaborations:

Throughout his career, Michael S. O'Reilly has collaborated with leading tech companies, research institutions, and universities to bring his ideas to life and push the boundaries of innovation.

Conclusion:

In conclusion, Michael S. O'Reilly's relentless pursuit of innovation and his commitment to excellence have solidified his reputation as a visionary inventor in the ever-evolving world of technology.